Clinical Trials on the Recurrence of the Tumor in Japan
Total 170 results
-
Novartis PharmaceuticalsCompleted
-
Tomey CorporationCompletedEvaluate the Agreement and Precision of Device SS-1000 and the Predicate Device the Pentacam in a Reproducibility and Repeatability TrialJapan
-
Bristol-Myers SquibbOno Pharma USA IncCompletedCancer of Head and Neck | Cancer of the Head | Cancer of the NeckJapan
-
Yokohama City University Medical CenterNovartis PharmaceuticalsUnknown
-
Aichi Medical UniversityUnknown
-
BayerRecruitingAdvanced or Recurrent Solid Tumor Harboring an NTRK Gene FusionJapan
-
Kurume UniversityUnknownTo Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT ImagingJapan
-
Eisai Inc.Eisai LimitedCompletedLesions of the LiverJapan
-
Novartis PharmaceuticalsCompletedAdvanced or Recurrent Solid TumorsJapan
-
Showa UniversityCompletedto Compare the Effect of Two Types of IOLs | on the Incidence of Cystoid Macular Edema | After Cataract SurgeryJapan
-
Merck KGaA, Darmstadt, GermanyCompleted
-
NAUSICA InvestigatorsNPO International TRI NetworkCompletedPatency of the Radial ArteryJapan, India, Taiwan
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
Yosuke UchitomiRecruitingAdvanced Cancer | Recurrent Cancer | End of Life CareJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedAgitation Associated With Dementia of the Alzheimer's TypeJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedAgitation Associated With Dementia of the Alzheimer's TypeJapan
-
RS MedicalAccelerated Care Plus; Research Institute of Health and Science (RIHSE)Completed
-
Otsuka Pharmaceutical Co., Ltd.TerminatedAgitation Associated With Dementia of the Alzheimer's TypeJapan
-
Eli Lilly and CompanyShionogiCompletedOsteoarthritis of the KneeJapan
-
National Cancer Center, JapanEisai Co., Ltd.Active, not recruitingAdvanced or Recurrent Solid Tumors | FGFR Gene AlterationsJapan
-
Eli Lilly and CompanyShionogiCompletedOsteoarthritis of the KneeJapan
-
Institut de Recherches Internationales ServierNot yet recruitingMetastatic Adenocarcinoma of the PancreasJapan
-
Stryker Japan K.K.Unknown
-
Stryker Japan K.K.UnknownOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis of the Femoral HeadJapan
-
Teva Takeda Pharma Ltd.Completed
-
Novartis PharmaceuticalsRecruitingBRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid TumorJapan
-
Eisai Inc.CompletedKIF5B-RET-Positive Adenocarcinoma of the LungUnited States, Hong Kong, Japan, Taiwan, Singapore
-
Nihon Pharmaceutical Co., LtdCompletedChronic Inflammatory Demyelinating PolyneuropathyJapan
-
Janssen Research & Development, LLCRecruitingHemolytic Disease of the Fetus and NewbornIsrael, Netherlands, Japan, United States, Australia, Belgium, United Kingdom, Brazil, Germany
-
Nihon Pharmaceutical Co., LtdCompletedGuillain-Barré SyndromeJapan
-
SymBio PharmaceuticalsCompletedAssess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCLJapan
-
Japan Blood Products OrganizationCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Nihon Pharmaceutical Co., LtdCompleted
-
Astellas Pharma IncCompletedthe Maintenance Phase After Kidney TransplantationJapan
-
Daiichi Sankyo Co., Ltd.RecruitingTenosynovial Giant Cell TumorJapan
-
Nagoya UniversityJapan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.CompletedChronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Japan
-
National Center of Neurology and Psychiatry, JapanCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveJapan
-
BayerCompletedAdvanced or Recurrent Solid Tumor Harboring an NTRK Gene FusionJapan
-
NovartisMitsubishi Tanabe Pharma CorporationCompleted
-
University of ToyamaUnknown
-
Boston Scientific CorporationCompletedAtherosclerosis of Native Arteries of the Extremities, UnspecifiedBelgium, United States, United Kingdom, Japan, Austria, Canada, Germany
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell Carcinoma of the Head and NeckJapan
-
Boston Scientific CorporationCompletedAtherosclerosis of Native Arteries of the ExtremitiesNew Zealand, United States, Belgium, Canada, Japan, Germany, Austria
-
BiogenCompleted
-
NovartisMitsubishi Tanabe Pharma CorporationCompletedMultiple SclerosisJapan
-
Kyushu UniversityRecruitingPediatric Solid Tumors | Refractory/Relapse NeuroblastomaJapan
-
AstraZenecaCompletedAll Patients Treated With the ProductJapan